K. Tan

Risk factors and outcome associated with infection or colonization due to carbapenem-heteroresistant Escherichia coli

H. Huse, A. Wong-Beringer, Amanda B Chron, 2021, JAC-antimicrobial resistance.

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis

J. Abdul‐Mutakabbir, K. Tan, Anna Zhou, 2022, Tropical medicine and infectious disease.

Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia

W. Mack, A. Wong-Beringer, M. Lou, 2021, BMC Infectious Diseases.

Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates.

H. Huse, A. Wong-Beringer, K. Tan, 2020, The Journal of antimicrobial chemotherapy.

In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study

A. Wong-Beringer, P. Jorth, M. Algorri, 2022, mSphere.